BMS-814580
BMS-814580 is an orally active, highly efficacious MCHR1 inhibitor with a Ki of 16.9 nM against hMCHR1. BMS-814580 shows antiobesity activities.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1197420-11-3
- 화학식: C24H19ClF2N2O4S
- 분자량:504.93
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
Ki: 16.9 nM (MCHR1)[1]
In Vitro
BMS-814580 (3.0 μM; 10 min) shows stability with 90%, 95% and 100% remaining in human, rat and mouse liver microsomes, respectively[1].
BMS-814580 displays modest in vitro ion channel inhibition of 43%, 21%, and 15%, respectively, for hERG, Na (4 Hz), and L-type Ca channels at 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Obese male SD rats, chronic diet-induced obese (DIO) rat model[1]
-
Dosage:0.03, 0.1, 0.3, 1 and 3 mg/kg
-
Administration:Orally administered as the phosphate prodrug, once daily for 28 days
-
Result:Dose dependently reduced body weight.
-
Animal Model:Sprague-Dawley Rats[1]
-
Dosage:10 mg/kg
-
Administration:Oral administration, once
-
Result:Pharmacokinetics (PK) and Pharmacodynamics (PD) Data: Plasma and Brain Concentrations of Cyclic Tertiary Alcohols and the Effect on Body Weights in Sprague-Dawley Rats
8 h rat PK studyb 4-day PD studyc day 4 parent compd concn at 20 h compd dosed asa AUC (μM•h) brain (nM) plasma (nM) % weight loss brain (nM) plasma (nM) BMS-814580 glycinate 38.1 11330 4500 6.4d 7955 12801
aRats were dosed orally with parent compound or a prodrug; prodrugs doses were adjusted to parent compounds. Vehicle = 0.5% Methocel, 0.1% Tween 80, 99.4% distilled water. bDose = 10 mg/kg; plasma and brain concentrations are reported 8 h after dose, n = 2. cCompounds were dosed at 3, 10, and 30 mg/kg orally once a day for 4 days; weight loss data is reported only for the 10 mg/kg dose, n = 8; reduction in body weight is reported as % change from baseline body weight compared to vehicle treated animals. NT = not tested. dNo biliary lesions were seen in this model.
-
Animal Model:Sprague-Dawley Rats[1]
-
Dosage:10 mg/kg (phosphate prodrug) or 1 mg/kg
-
Administration:Oral (phosphate prodrug) or intravenous administration (Pharmacokinetic Analysis)
-
Result:Pharmacokinetics Data for BMS-814580 in Rata
species compd (mg/kg) route of admin Cmax (μM) Tmax (h) AUC0−∞ (μM•h) T1/2 (h) CL (mL/min/kg) Vss(L/kg) F (%) rat BMS-814580 (1) iv 11.5 >24 0.9 4.1 BMS-814580 phosphate (10) po 4.0 6.7 107 54
aVehicles: iv, PEG400/DMAC/water (70:5:25); po, Methocel/Tween80/water (0.5:0.1:99.4).
Chemical Information
-
CAS No. 1197420-11-3
-
분자량 504.93
-
화학식 C24H19ClF2N2O4S
-
SMILES
O=C1C2=C(N=CN1C3=CC=C(OCC4(O)CC(C4)(F)F)C(OC)=C3)C=C(S2)C5=CC=C(C=C5)Cl
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)